$CRWDNeutralLow

GANDHI SAMEER K sold $214K of CRWD (indirect holdings)

GANDHI SAMEER K sold 274 indirectly-held shares of CrowdStrike Holdings, Inc. (CRWD) at $781.38 ($0.21M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

6/10
3/10
Low
Neutral
Filed June 3; sale executed June 1 under a 10b5-1 plan.
Neutral—insider selling under 10b5-1 typically has muted read-through.

This is an insider selling disclosure; it may affect near-term sentiment but does not indicate a new fundamental catalyst.

CrowdStrike director GANDHI SAMEER K sold 274 shares ($214,098.12) via an open-market transaction under a 10b5-1 plan.

Likely limited/short-lived impact; any move would be sentiment-driven rather than fundamentals.

Background

SEC Form 4 reports insider transactions; a 10b5-1 plan means trades were pre-scheduled, often lowering interpretive value.

Why it matters

The disclosure updates ownership records but does not provide new operational, financial, or regulatory information.

Market relevance

Insider selling under a pre-arranged plan is usually not a standalone trading catalyst.

Market effects

No clear sector read-through; insider Form 4s are company-specific and usually not sector catalysts.

None indicated.

None indicated.

Alternative perspectives

Even with 10b5-1, repeated insider selling can still coincide with internal caution; traders may watch for follow-on sales.

The sale size is small relative to typical CRWD float; without additional context (e.g., multiple filings, option exercises), the signal is weak.

Key entities

  • CrowdStrike Holdings, Inc.

    Issuer of the reported insider sale; director sold 274 shares for ~$214.1K under a 10b5-1 plan.

  • GANDHI SAMEER K

    Director who executed the open-market sale disclosed on Form 4.

Related articles

$CRWDMed

Weakness May Be an Opportunity for CrowdStrike Stock

CrowdStrike said demand for its Falcon platform and broader security offerings remains strong as cybersecurity spending grows, including amid AI adoption, according to management. The company raised full-year ARR guidance to $6.53B–$6.56B and increased revenue and earnings guidance. Analysts: 34 “Strong Buy,” 3 “Moderate Buy,” 11 “Hold,” 2 “Strong Sell” (consensus “Moderate Buy”); mean target $723.74 and high $825.

$ZSMedAI 9/10

Cybersecurity Earnings: 1 AI Standout and 2 Stocks Under Pressure

Zscaler shares fell more than 31% after fiscal Q3 2026 results, despite revenue of $850M+ (+25% YoY vs. $835M est.) and adjusted EPS of $1.08 (+28% YoY vs. $1.01 est.). The company raised full-year revenue growth to 24.6%–24.7% but cut its free-cash-flow margin outlook (midpoint 26.75% to 23.1%) and guided 16%–17% ARR growth next year. CrowdStrike slipped about 7% after fiscal Q1 2027 beats and a raise; revenue was $1.39B (+26% YoY), EPS $1.10 (+51% YoY), and net new ARR growth guidance increase

$CRWDLow

Rosenblatt Lifts PT on CrowdStrike (CRWD) Following “Outstanding” Q1

Rosenblatt raised its CrowdStrike (CRWD) price target to $825 from $640 and kept a Buy rating after what it called an “outstanding” fiscal Q1. The firm said shares fell about 11% after hours, attributing it to profit taking after an ~87% post-earnings rise, and cited the “Mythos moment” and Falcon’s role in AI cybersecurity. Wedbush also raised its target to $720 from $700, maintaining Outperform.

$CRWDLow

Is CrowdStrike Stock a Buy on the Dip?

CrowdStrike shares fell after fiscal Q1 results, despite the company raising its full-year ARR growth outlook to 27%–29% from 23%–24%, according to the report. Ending ARR rose 24% to $5.51B and net new ARR 32% to $256M. Revenue grew 26% to $1.39B; adjusted EPS rose 51% to $1.10. Fiscal 2027 revenue guidance was $5.915B–$5.959B and adjusted EPS $4.88–$4.96.